Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B6130 Trihexyphenidyl hydrochlorideSummary: antiparkinsonian agent of the antimuscarinic class
- B6132 Fluphenazine dihydrochlorideSummary: phenothiazine-class D1DR and D2DR inhibitor
- B6137 DiflunisalSummary: COX inhibitor, nonsteroidal anti-inflammatory drug (NSAID)
- B6138 Itopride hydrochlorideSummary: AChE inhibitor
- B6139 (+/-)-SulfinpyrazoneSummary: platelet COX inhibitor
- B6142 NetupitantSummary: neurokinin 1 (NK1) receptor antagonist
- B6147 CarbinoxaMine MaleateSummary: histamine-H1 receptor inhibitor
- B6156 CinnarizineSummary: antihistamine and calcium channel blocker
- B6157 PerphenazineSummary: A dopamine antagonist
- B6195 Verubecestat (MK-8931)Summary: BACE1 inhibitor